ovarian: Ovarian Cancer Survival Data

Description Usage Format Source References

Description

Survival in a randomised trial comparing two treatments for ovarian cancer

Usage

1

Format

futime

survival or censoring time

fustat

censoring status

age

in years

resid.ds

residual disease present (1=no,2=yes)

rx

treatment group

ecog.ps

ECOG performance status (1 is better, see reference)

Source

Terry Therneau

References

Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979.


danzafar/tidyspark documentation built on Sept. 30, 2020, 12:19 p.m.